Market capitalisation, EUR | 224,608.93 m |
EPS, EUR | 6.84 |
P/B ratio | 5.74 |
P/E ratio | 15.06 |
Dividend yield | 2.86% |
Revenue, EUR | 42,031.24 m |
Net income, EUR | 7,925.26 m |
Profit margin | 18.86% |
ETF | Weight | Investment focus | Holdings | TER | Fund size (in m EUR) | Return 1Y | WKN | ISIN |
---|---|---|---|---|---|---|---|---|
First Trust Value Line® Dividend Index UCITS ETF Acc | 0.53% | Equity United States Dividend | 191 | 0.70% | 14 | +9.12% | A2PZMV | IE00BKVKW020 |
L&G Pharma Breakthrough UCITS ETF | 2.40% | Equity World Health Care Innovation | 43 | 0.49% | 17 | -1.66% | A2H9XR | IE00BF0H7608 |
YTD | +7.59% |
1 month | +2.06% |
3 months | +12.21% |
6 months | +0.75% |
1 year | +12.45% |
3 years | +29.03% |
5 years | - |
Since inception (MAX) | +21.42% |
2023 | +4.16% |
2022 | +16.57% |
2021 | - |
2020 | - |
Volatility 1 year | 16.65% |
Volatility 3 years | 18.54% |
Volatility 5 years | - |
Return per risk 1 year | 0.75 |
Return per risk 3 years | 0.48 |
Return per risk 5 years | - |
Maximum drawdown 1 year | -12.83% |
Maximum drawdown 3 years | -14.51% |
Maximum drawdown 5 years | - |
Maximum drawdown since inception | -14.67% |